Your browser doesn't support javascript.
loading
What about the relevance of PIP of psychotropics in older psychiatric inpatients?
Houix, Morgane; Humbert, Ilia; D'Acremont, Fanny; Sauvaget, Anne; Huon, Jean-François; Bulteau, Samuel.
Afiliação
  • Houix M; Service pharmacie, centre hospitalier universitaire de Nantes, 44000 Nantes, France. Electronic address: morgane.houix@chu-nantes.fr.
  • Humbert I; Unité PPANs, centre hospitalier universitaire de Strasbourg, 67091 Strasbourg, France.
  • D'Acremont F; Service pharmacie, centre hospitalier universitaire de Nantes, 44000 Nantes, France; OMEDIT Pays de la Loire, 44000 Nantes, France.
  • Sauvaget A; Département de psychiatrie et addictologie, centre hospitalier universitaire de Nantes, 44000 Nantes, France.
  • Huon JF; Service pharmacie, centre hospitalier universitaire de Nantes, 44000 Nantes, France.
  • Bulteau S; Département de psychiatrie et addictologie, centre hospitalier universitaire de Nantes, 44000 Nantes, France.
Encephale ; 2024 Jul 08.
Article em En | MEDLINE | ID: mdl-38981810
ABSTRACT

OBJECTIVE:

In 2019, a regional survey of potentially inappropriate prescriptions (PIP) of psychotropic drugs in elderly psychiatric inpatients was carried out highlighting their inappropriate use in this population. The aim of this study was to assess the clinical relevance - defined as the provision of an appropriate and necessary treatment, chosen from other alternatives as being the most likely to produce the expected results for a given patient - of these prescriptions considered inappropriate according to current established criteria. MATERIAL AND

METHOD:

Patients aged over 75, or 64 to 75 and polypathological with at least one PIP of psychotropic drugs or drugs with a high anticholinergic burden, identified by an audit grid established on the basis of STOPP/STARTv2 criteria and the Laroche list on the prescription at 48h of hospitalization, were included. The weighing of the inappropriateness nature of the prescription (resistance to treatment, period of crisis, comorbidities…) was established by a pharmacist-psychiatrist pair on the entire computerized record of the current episode. The clinical relevance of the PIP and the overall prescription was rated as 0 (irrelevant), 1 (partially relevant) or 2 (relevant).

RESULTS:

Thirty-four patients were included. One hundred and twenty-five PIP of psychotropic drugs were noted 50.4% concerned benzodiazepines and non-benzodiazepines anxiolytics (BZD/Z), 25.6% neuroleptics (NL), 12% antidepressants (ATD) and 12% drugs with a high anticholinergic burden. On one hand, 49.2% of PIP of BZD/Z, 50% of PIP of NL and 20% of PIP of ATD were considered irrelevant. On the other hand, 49.2% of PIP of BZD/Z, 31.3% of PIP of NL and 13.3% of PIP of ATD were considered partially relevant. Furthermore, 1.6% of PIP of BZD/Z, 18.8% of PIP of NL and 66.7% of PIP of ATD were considered relevant. For PIPs of drugs with a high anticholinergic burden, 80% were deemed irrelevant, 13.3% partially relevant and 6.7% relevant. In all, of the 34 drug prescriptions studied, three (8.8%) were considered irrelevant, 11 (32.4%) partially relevant and 20 (58.8%) clinically relevant.

CONCLUSION:

This study highlighted the clinical relevance of more than half the prescriptions considered inappropriate according to current PPI criteria in the elderly. It underlines the interest of a new PPI detection tool for elderly patients with psychiatric disorders.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article